Case Study: Adicet Bio achieves scalable, IND-ready data infrastructure for next-generation cell therapies with Benchling

Adicet Bio Building a Data Infrastructure for Next-Generation Cell Therapies

Adicet Bio, a developer of next-generation cell therapies, faced a growing data challenge as it scaled operations across sites in California and Israel. Critical experimental records were fragmented across paper notebooks, employee computers, and public drives, and their prior platform could not deliver the fine-grained access controls or standardized capture needed to support complex R&D workflows and regulatory readiness.

Adicet adopted Benchling to unify data on a single, bio-intelligent platform: Notebook entries link to Registry entities, configurable templates and folder structures standardize recordkeeping, and tiered permissions let them grant read, write, or admin access to teams and external consultants as needed. The result is centralized, auditable data that supports IND filing, accelerates collaboration and onboarding as the company scales, and positions Adicet to move therapies more rapidly into the clinic.

Adicet Bio

Jeanette Grant

Associate Director of Project Management